Psychedelic Medicine Podcast with Dr. Lynn Marie Morski Psilocybin for Addressing Burnout with Tracy Kim Townsend, MD
In this episode, Tracy Kim Townsend, MD, joins to discuss the potential efficacy of psilocybin therapy for addressing burnout, particularly in healthcare professionals. Dr. Townsend is a Harvard-trained medical doctor, licensed psilocybin facilitator, and the Co-Founder & CEO of Meadow Medicine, one of the only legal psilocybin service centers based in the U.S., founded and led by an MD.
In this conversation, Dr. Townsend gives an overview of burnout and discusses its prevalence amongst healthcare professionals due to the intense nature of these professions. She mentions the relevance of the wounded healer archetype for many physicians and how this identity can intersect with experiences of burnout. Turning to psilocybin therapy, Dr. Townsend discusses how these psychedelic treatments can help address burnout through promoting neuroplasticity and facilitating effective emotional processing. Following these experiences, patients are often much better poised to make well-considered life changes to help stave off burnout. Dr. Townsend concludes by emphasizing the importance of integration following psychedelic journeys to ensure maximal benefit and effectiveness of these treatments.
In this episode, you'll hear:
- How burnout develops
- How technology and culture have contributed to the rise of burnout
- The symptoms of burnout
- Supporting career longevity for physicians
- How psilocybin may support patients looking to address burnout
- Clinical research into psilocybin for burnout in healthcare professionals
- Why loosening the grip on one’s identity and ego dissolution may be tied to the therapeutic benefits of psychedelics
Quotes:
“One core area that I see psilocybin playing a role [for addressing burnout] is just creating these spaces where we can process emotions and integrate them.” [21:41]
“SSRIs, which are the gold standard intervention right now for depression, usually result in about a nine-point drop [in depression scores on the Montgomery-Åsberg Depression Rating Scale], which is really no better than placebo… Whereas psilocybin showed a three-fold drop—there’s really no intervention for depression we see with that dramatic of results.” [25:17]
“Another thing that I think is remarkable, too is… you continue to see the benefits—if you check scores immediately after the [psilocybin] journey and then at six months out, there continues to be improvement in mental health scores.” [29:06]
Links:
Psychedelic Medicine Association